Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in Pediatric Crohnʼs Disease-Reference-Cited by-同舟云学术

Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in Pediatric Crohnʼs Disease

Published:2009-12 Issue:12 Volume:104 Page:3042-3049
ISSN:0002-9270
Container-title:American Journal of Gastroenterology
language:en
Short-container-title:American Journal of Gastroenterology

Author:

Rosh Joel R.,Lerer Trudy,Markowitz James,Goli Sri R.,Mamula Petar,Noe Joshua D.,Pfefferkorn Marian D.,Kelleher Kathleen T.,Griffiths Anne M.,Kugathasan Subra,Keljo David,Oliva-Hemker Maria,Crandall Wallace,Carvalho Ryan S.,Mack David R.,Hyams Jeffrey S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Link

http://www.nature.com/articles/ajg2009493.pdf

Reference26 articles.

1. Unravelling the pathogenesis of inflammatory bowel disease

2. The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study

3. Corticosteroid Therapy in the Age of Infliximab: Acute and 1-Year Outcomes in Newly Diagnosed Children With Crohn’s Disease

4. A controlled double blind study of azathioprine in the management of Crohn's disease.

5. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adalimumab Biosimilar in Pediatric Inflammatory Bowel Disease: A Retrospective Study from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD);Healthcare;2024-02-04

2. Durability of Adalimumab and Infliximab in Children With Crohn’s Disease: A Nationwide Comparison From the epi-IIRN Cohort;Inflammatory Bowel Diseases;2024-01-08

3. Efficacy and safety of adalimumab in pediatric patients with Crohn’s disease: A systematic review and meta-analysis;European Journal of Clinical Pharmacology;2023-12-29

4. Managing pediatric Crohn’s disease: recent insights;Expert Review of Gastroenterology & Hepatology;2023-10-03

5. The Future of Advanced Therapies for Pediatric Crohn’s Disease;Pediatric Drugs;2023-08-23